Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 214 | 360 | 218 | 372 | 199 |
| Gross Profit | 214 | 360 | 218 | 372 | 199 |
| Operating Expenses | 28,838 | 25,915 | 24,710 | 29,432 | 25,679 |
| Operating Income | -28,624 | -25,555 | -24,492 | -29,060 | -25,480 |
| Interest Expense | 496 | 506 | 520 | 527 | 530 |
| Other Income | 40 | 87 | 139 | 48 | 79 |
| Pre-tax Income | -29,080 | -25,974 | -24,873 | -29,539 | -25,931 |
| Net Income Continuous | -29,080 | -25,974 | -24,873 | -29,539 | -25,931 |
| Net Income | $-29,080 | $-25,974 | $-24,873 | $-29,539 | $-25,931 |
| EPS Basic Total Ops | -0.42 | -0.35 | -0.42 | -0.42 | -0.35 |
| EPS Basic Continuous Ops | -0.40 | -0.35 | -0.34 | -0.42 | -0.38 |
| EPS Diluted Total Ops | -0.42 | -0.35 | -0.42 | -0.42 | -0.35 |
| EPS Diluted Continuous Ops | -0.40 | -0.35 | -0.34 | -0.42 | -0.38 |
| EBITDA(a) | $-27,799 | $-24,762 | $-23,576 | $-28,005 | $-24,386 |